{"organizations": [], "uuid": "1f89e54cf4f473645940e1ee8d08707281787522", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180117.html", "section_title": "Archive News &amp; Video for Wednesday, 17 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zhejiang-jolly-pharmaceutical-unit/brief-zhejiang-jolly-pharmaceutical-unit-to-set-up-industry-buyout-fund-to-invest-in-biomedicine-firm-idUSL3N1PC3D1", "country": "US", "domain_rank": 408, "title": "BRIEF-Zhejiang Jolly Pharmaceutical unit to set up industry buyout fund to invest in biomedicine firm", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-17T17:59:00.000+02:00", "replies_count": 0, "uuid": "1f89e54cf4f473645940e1ee8d08707281787522"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zhejiang-jolly-pharmaceutical-unit/brief-zhejiang-jolly-pharmaceutical-unit-to-set-up-industry-buyout-fund-to-invest-in-biomedicine-firm-idUSL3N1PC3D1", "ord_in_thread": 0, "title": "BRIEF-Zhejiang Jolly Pharmaceutical unit to set up industry buyout fund to invest in biomedicine firm", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-zhejiang jolly pharmaceutical", "sentiment": "negative"}, {"name": "reuters) - zhejiang jolly pharmaceutical co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 17(Reuters) - Zhejiang Jolly Pharmaceutical Co Ltd\n* Says co’s wholly owned medical unit to set up an industry buyout fund with partner to invest in a Shanghai-based biomedicine firm, with fund’s investment amount of up to 120 million yuan\n* Says unit is holding 7.85 percent stake in the Shanghai-based biomedicine firm\nSource text in Chinese: goo.gl/5coZzb\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/5coZzb", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-17T17:59:00.000+02:00", "crawled": "2018-01-18T16:18:40.000+02:00", "highlightTitle": ""}